Is everyone sleeping on $Novo-

2025-08-04

Is everyone sleeping on $Novo-Nordisk A/S(NVO)$ 's FDA submission for 25mg oral Semaglutide? 15-17% weight loss data with decision expected by year-end. Their EU application for 7.2mg Wegovy injection shows over 21% efficacy. Pipeline bombshells CagriSema and oral Amycretin are crushing Phase 3 trials. Despite $Novo-Nordisk A/S(NVO)$ 's marketing team needing lessons from $Eli Lilly(LLY)$ , becoming first-mover in oral obesity meds could launch their market cap into orbit. Medicare coverage would be the ultimate catalyst.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

BernardLL
2025-08-04
BernardLL
Means good or bad??

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":463949178093576,"tweetId":"463949178093576","gmtCreate":1754286814000,"gmtModify":1754289090635,"author":{"id":10000000000011064,"idStr":"10000000000011064","authorId":10000000000011064,"authorIdStr":"10000000000011064","name":"Rupert Aldridge","avatar":"https://static.tigerbbs.com/077c9741330a77a132d48c1f9ae3264c","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":40,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Is everyone sleeping on <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>'s FDA submission for 25mg oral Semaglutide? 15-17% weight loss data with decision expected by year-end. Their EU application for 7.2mg Wegovy injection shows over 21% efficacy. Pipeline bombshells CagriSema and oral Amycretin are crushing Phase 3 trials. Despite <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>'s marketing team needing lessons from <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$&nbsp;</a>, becoming first-mover in oral obesity meds could launch their market cap into orbit. Medicare coverage would be the ultimate catalyst.</p></body></html>","htmlText":"<html><head></head><body><p>Is everyone sleeping on <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>'s FDA submission for 25mg oral Semaglutide? 15-17% weight loss data with decision expected by year-end. Their EU application for 7.2mg Wegovy injection shows over 21% efficacy. Pipeline bombshells CagriSema and oral Amycretin are crushing Phase 3 trials. Despite <a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a>'s marketing team needing lessons from <a href=\"https://ttm.financial/S/LLY\">$Eli Lilly(LLY)$&nbsp;</a>, becoming first-mover in oral obesity meds could launch their market cap into orbit. Medicare coverage would be the ultimate catalyst.</p></body></html>","text":"Is everyone sleeping on $Novo-Nordisk A/S(NVO)$ 's FDA submission for 25mg oral Semaglutide? 15-17% weight loss data with decision expected by year-end. Their EU application for 7.2mg Wegovy injection shows over 21% efficacy. Pipeline bombshells CagriSema and oral Amycretin are crushing Phase 3 trials. Despite $Novo-Nordisk A/S(NVO)$ 's marketing team needing lessons from $Eli Lilly(LLY)$ , becoming first-mover in oral obesity meds could launch their market cap into orbit. Medicare coverage would be the ultimate catalyst.","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":4,"favoriteSize":0,"link":"https://ttm.financial/post/463949178093576","repostId":0,"isVote":1,"tweetType":1,"viewCount":834,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["LLY","NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":452,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":463993748796256,"commentId":"463993748796256","gmtCreate":1754304970890,"gmtModify":1754304976362,"authorId":3567412323589940,"author":{"id":3567412323589940,"idStr":"3567412323589940","authorId":3567412323589940,"name":"BernardLL","avatar":"https://community-static.tradeup.com/news/394a3bcfbe9cedca3b2695131f57bb6d","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.63%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":12,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":463949178093576,"objectIdStr":"463949178093576","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Means good or bad??","text":"Means good or bad??","html":"Means good or bad??","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/463949178093576"}